Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level.
To our knowledge, there is little information about functional thrombin activatable fibrinolysis inhibitor (TAFI) levels and the risk of acute coronary artery disease (CAD). We investigated the risk of acute CAD related to plasma levels of functional TAFI. We found that functional TAFI levels in plasma (above 126%), increased the risk of acute CAD almost 4-fold.
Santamaría
Amparo
A
Martínez-Rubio
Antonio
A
Borrell
Montserrat
M
Mateo
José
J
Ortín
Rosa
R
Fontcuberta
Jordi
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D025901:Carboxypeptidase B2 / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
D025901:Carboxypeptidase B2